Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.
Steiner
Hans Herbert
HH
Department of Neurosurgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. hsteiner@med.uni-heidelberg.de
Bonsanto
Matteo Mario
MM
Beckhove
Philipp
P
Brysch
Michael
M
Geletneky
Karsten
K
Ahmadi
Rezvan
R
Schuele-Freyer
Rebecca
R
Kremer
Paul
P
Ranaie
Golamreza
G
Matejic
Dejana
D
Bauer
Harald
H
Kiessling
Marika
M
Kunze
Stefan
S
Schirrmacher
Volker
V
Herold-Mende
Christel
C
D018109:Avulavirus; D019496:Cancer Vaccines / Q000494:pharmacology*; D016022:Case-Control Studies; D016543:Central Nervous System Neoplasms / Q000276:immunology* / Q000628:therapy*; D005240:Feasibility Studies; D005260:Female; D005909:Glioblastoma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D016233:Immunotherapy, Active; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011379:Prognosis; D015996:Survival Rate; D014407:Tumor Cells, Cultured
D019496:Cancer Vaccines